| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 14, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 14, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Save time and jump to the most important pieces.
Roseland, NJ, April 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of the AI-enabled Gaxos Health mobile application for iOS and Android for its customers. The new AI-driven app is designed to personalize and optimize individual health outcomes through smart technology and science-backed routines. The Gaxos Health app leverages proprietary algorithms to deliver goal-based wellness protocols including nutrition, fitness, supplementation, and behavioral coaching. "We are thrilled to announce the launch of the Gaxos Health app," said Vadim Mats, CEO
Roseland, NJ, March 05, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company has acquired AI technology to bolster its content creation services. This acquisition immediately expands the capabilities of Gaxos Labs and enhances the Company's broader AI development initiatives, setting the stage for growth. This strategic addition equips Gaxos with AI solutions, including advanced text-to-speech (TTS), high-quality image generation, dynamic video assembly, instant narration, enhanced styling, and script automation, unlocking unprecedented possibilities for both u
ROSELAND, NJ, March 04, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ:GXAI) ("the Company"), a company developing artificial intelligence applications across various sectors, today announced that the Company has reincorporated in the State of Nevada from State of Delaware (the "Reincorporation"). The Reincorporation was previously approved by the board of directors of the Company, and subsequently approved by the stockholders of the Company at the Company's Annual Meeting of stockholders held on December 27, 2024. The Company is now subject to the Nevada Revised Statutes. The Reincorporation did not affect any of the Company's contracts with any third parties, and the Company's right
10-K - GAXOS.AI INC. (0001895618) (Filer)
8-K12B - GAXOS.AI INC. (0001895618) (Filer)
8-K - GAXOS.AI INC. (0001895618) (Filer)
SC 13G - GAXOS.AI INC. (0001895618) (Subject)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D. is a Board-Ce
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio